Cipla Limited (CIPLA.NS) is in Healthcare, Drug Manufacturers - Specialty & Generic, based in India, listed on NSE. Market cap 1.10T INR. 52-week range 1,165.70 to 1,593.30 INR. Trailing P/E 38.1. Data as of 2026-10-28.
Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney disorders, alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central ...